Hormonal Abnormalities

Imbalances disrupting the menstrual cycle, ovulation, or early pregnancy. RRM diagnoses these through cycle-timed blood tests guided by fertility charting. Key hormones evaluated include:

  • FSH (Follicle-Stimulating Hormone): Stimulates follicular development; elevated early-cycle FSH indicates diminished ovarian reserve
  • LH (Luteinizing Hormone): Surge triggers ovulation; chronically elevated in PCOS
  • Estradiol (E2): Primary estrogen; supports follicular development, cervical mucus production, and endometrial proliferation
  • Progesterone (P4): Luteal phase hormone critical for endometrial receptivity and early pregnancy; measured at post-peak +7 in NaPro protocols
  • hCG (Human Chorionic Gonadotropin): Produced by the implanting trophoblast; sustains the corpus luteum; measured for early pregnancy confirmation and monitoring
  • Prolactin: Elevated levels (hyperprolactinemia) suppress LH/FSH pulsatility, impairing ovulation and the luteal phase
  • AMH (Anti-Mullerian Hormone): Secreted by ovarian granulosa cells; marker of ovarian reserve; low in diminished ovarian reserve (DOR)

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.